thiazolyl blue has been researched along with Epstein-Barr Virus Infections in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Donovan, J; Huang, D; Li, JH; Liu, FF; Weinrib, L | 1 |
1 other study(ies) available for thiazolyl blue and Epstein-Barr Virus Infections
Article | Year |
---|---|
Cisplatin chemotherapy plus adenoviral p53 gene therapy in EBV-positive and -negative nasopharyngeal carcinoma.
Topics: Adenoviridae; Antineoplastic Agents; beta-Galactosidase; Blotting, Western; Cell Survival; Cisplatin; Combined Modality Therapy; Epstein-Barr Virus Infections; Gene Expression; Genetic Therapy; Genetic Vectors; Herpesvirus 4, Human; Humans; Nasopharyngeal Neoplasms; Tetrazolium Salts; Thiazoles; Transfection; Tumor Suppressor Protein p53 | 2001 |